| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malnutrition | 59 | 2025 | 205 | 13.750 |
Why?
|
| Growth Disorders | 31 | 2021 | 209 | 7.550 |
Why?
|
| Child Nutrition Disorders | 35 | 2021 | 75 | 7.420 |
Why?
|
| Malawi | 99 | 2021 | 397 | 5.640 |
Why?
|
| Food, Fortified | 34 | 2023 | 96 | 5.390 |
Why?
|
| Dietary Supplements | 37 | 2021 | 476 | 5.100 |
Why?
|
| Severe Acute Malnutrition | 14 | 2023 | 21 | 4.780 |
Why?
|
| Rural Population | 38 | 2025 | 256 | 4.490 |
Why?
|
| Nutritional Status | 28 | 2023 | 314 | 4.390 |
Why?
|
| Dietary Proteins | 18 | 2019 | 251 | 3.700 |
Why?
|
| Infant Nutritional Physiological Phenomena | 27 | 2022 | 193 | 3.550 |
Why?
|
| Kwashiorkor | 26 | 2023 | 48 | 3.500 |
Why?
|
| Diet | 25 | 2021 | 1138 | 3.490 |
Why?
|
| Infant | 138 | 2025 | 12473 | 3.330 |
Why?
|
| Intestinal Diseases | 11 | 2021 | 83 | 3.220 |
Why?
|
| Feces | 27 | 2025 | 726 | 3.210 |
Why?
|
| Protein-Energy Malnutrition | 15 | 2022 | 76 | 3.160 |
Why?
|
| Weight Gain | 29 | 2020 | 401 | 3.110 |
Why?
|
| Food, Formulated | 13 | 2021 | 52 | 2.970 |
Why?
|
| Milk | 12 | 2024 | 119 | 2.920 |
Why?
|
| Zea mays | 22 | 2021 | 43 | 2.880 |
Why?
|
| Child, Preschool | 124 | 2024 | 14018 | 2.680 |
Why?
|
| Fast Foods | 11 | 2023 | 35 | 2.680 |
Why?
|
| Child Nutritional Physiological Phenomena | 18 | 2018 | 173 | 2.630 |
Why?
|
| Fabaceae | 6 | 2024 | 24 | 2.600 |
Why?
|
| Body Height | 18 | 2020 | 215 | 2.490 |
Why?
|
| Zinc | 14 | 2018 | 128 | 2.250 |
Why?
|
| Intestinal Mucosa | 11 | 2018 | 776 | 2.130 |
Why?
|
| Intestinal Absorption | 13 | 2018 | 190 | 2.070 |
Why?
|
| Infant Nutrition Disorders | 13 | 2021 | 28 | 1.990 |
Why?
|
| Malabsorption Syndromes | 6 | 2017 | 36 | 1.940 |
Why?
|
| Lactulose | 14 | 2023 | 39 | 1.890 |
Why?
|
| Micronutrients | 10 | 2018 | 69 | 1.750 |
Why?
|
| Child Development | 17 | 2021 | 267 | 1.710 |
Why?
|
| Gastrointestinal Microbiome | 9 | 2024 | 698 | 1.710 |
Why?
|
| Permeability | 8 | 2024 | 122 | 1.630 |
Why?
|
| Humans | 211 | 2025 | 124867 | 1.620 |
Why?
|
| Amoxicillin | 4 | 2016 | 121 | 1.590 |
Why?
|
| Vigna | 4 | 2024 | 6 | 1.540 |
Why?
|
| Sierra Leone | 12 | 2024 | 30 | 1.420 |
Why?
|
| Home Care Services | 8 | 2019 | 68 | 1.420 |
Why?
|
| Mannitol | 9 | 2018 | 48 | 1.400 |
Why?
|
| Male | 122 | 2025 | 61375 | 1.360 |
Why?
|
| Female | 127 | 2025 | 66655 | 1.350 |
Why?
|
| HIV Wasting Syndrome | 4 | 2010 | 4 | 1.340 |
Why?
|
| Double-Blind Method | 19 | 2024 | 1642 | 1.300 |
Why?
|
| RNA, Ribosomal, 16S | 6 | 2024 | 367 | 1.290 |
Why?
|
| Environment | 6 | 2017 | 145 | 1.250 |
Why?
|
| Food Assistance | 2 | 2021 | 36 | 1.240 |
Why?
|
| Amino Acids, Essential | 3 | 2021 | 26 | 1.230 |
Why?
|
| Nutrition Therapy | 3 | 2021 | 12 | 1.160 |
Why?
|
| Nutritive Value | 8 | 2018 | 91 | 1.090 |
Why?
|
| RNA, Messenger | 7 | 2021 | 2815 | 1.080 |
Why?
|
| Plant Oils | 3 | 2020 | 32 | 1.060 |
Why?
|
| Metabolomics | 5 | 2024 | 422 | 1.050 |
Why?
|
| Intestine, Small | 6 | 2020 | 310 | 1.040 |
Why?
|
| Intestines | 5 | 2020 | 574 | 1.030 |
Why?
|
| Campylobacter | 5 | 2025 | 25 | 1.010 |
Why?
|
| Choline | 4 | 2023 | 54 | 0.980 |
Why?
|
| Manihot | 5 | 2013 | 8 | 0.980 |
Why?
|
| Anti-Bacterial Agents | 6 | 2021 | 2428 | 0.970 |
Why?
|
| Phytic Acid | 5 | 2015 | 10 | 0.970 |
Why?
|
| Child | 54 | 2024 | 24399 | 0.960 |
Why?
|
| Acute Disease | 15 | 2020 | 1108 | 0.960 |
Why?
|
| Eggs | 3 | 2021 | 24 | 0.940 |
Why?
|
| Dietary Fats | 8 | 2016 | 296 | 0.900 |
Why?
|
| Avena | 2 | 2023 | 2 | 0.890 |
Why?
|
| Developing Countries | 12 | 2021 | 270 | 0.880 |
Why?
|
| Infant Food | 5 | 2015 | 81 | 0.860 |
Why?
|
| Milk Proteins | 6 | 2020 | 92 | 0.860 |
Why?
|
| Infection Control | 2 | 2022 | 155 | 0.860 |
Why?
|
| Cost-Benefit Analysis | 4 | 2021 | 509 | 0.850 |
Why?
|
| Soy Foods | 7 | 2012 | 9 | 0.850 |
Why?
|
| Flour | 5 | 2018 | 7 | 0.840 |
Why?
|
| Amino Acids | 7 | 2024 | 664 | 0.840 |
Why?
|
| Wasting Syndrome | 4 | 2020 | 25 | 0.830 |
Why?
|
| Food Analysis | 4 | 2018 | 26 | 0.830 |
Why?
|
| Cognition | 4 | 2022 | 731 | 0.820 |
Why?
|
| Microbiota | 3 | 2020 | 388 | 0.800 |
Why?
|
| Anthropometry | 12 | 2022 | 199 | 0.790 |
Why?
|
| Cephalosporins | 2 | 2013 | 137 | 0.780 |
Why?
|
| Enteritis | 3 | 2017 | 54 | 0.770 |
Why?
|
| Dietary Carbohydrates | 4 | 2019 | 119 | 0.770 |
Why?
|
| Sanitation | 2 | 2019 | 17 | 0.770 |
Why?
|
| Leucine | 6 | 2013 | 311 | 0.760 |
Why?
|
| Albendazole | 3 | 2021 | 29 | 0.760 |
Why?
|
| HIV Infections | 12 | 2015 | 1889 | 0.750 |
Why?
|
| Counseling | 3 | 2023 | 218 | 0.740 |
Why?
|
| Plant Proteins | 2 | 2020 | 76 | 0.740 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 512 | 0.740 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2021 | 117 | 0.720 |
Why?
|
| Carnitine | 3 | 2024 | 74 | 0.720 |
Why?
|
| Infant Mortality | 1 | 2022 | 173 | 0.720 |
Why?
|
| Growth | 5 | 2020 | 106 | 0.720 |
Why?
|
| Colostrum | 1 | 2021 | 56 | 0.710 |
Why?
|
| Gastrointestinal Diseases | 5 | 2020 | 336 | 0.710 |
Why?
|
| Treatment Outcome | 35 | 2023 | 12398 | 0.710 |
Why?
|
| Feeding Behavior | 4 | 2017 | 701 | 0.700 |
Why?
|
| Food Quality | 3 | 2018 | 6 | 0.680 |
Why?
|
| Food Supply | 6 | 2023 | 101 | 0.680 |
Why?
|
| Anti-Retroviral Agents | 3 | 2010 | 139 | 0.680 |
Why?
|
| Diarrhea | 5 | 2020 | 317 | 0.670 |
Why?
|
| Nutrition Assessment | 6 | 2016 | 136 | 0.660 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2017 | 69 | 0.650 |
Why?
|
| Phaseolus | 2 | 2017 | 5 | 0.650 |
Why?
|
| Food | 6 | 2021 | 125 | 0.640 |
Why?
|
| Prospective Studies | 17 | 2023 | 6148 | 0.620 |
Why?
|
| Vitamin A | 3 | 2014 | 58 | 0.620 |
Why?
|
| Campylobacter Infections | 3 | 2025 | 34 | 0.620 |
Why?
|
| Consumer Behavior | 3 | 2016 | 39 | 0.620 |
Why?
|
| Acute-Phase Proteins | 5 | 2016 | 47 | 0.610 |
Why?
|
| Poverty | 3 | 2020 | 422 | 0.610 |
Why?
|
| Starch | 2 | 2015 | 25 | 0.610 |
Why?
|
| Prenatal Care | 1 | 2021 | 347 | 0.610 |
Why?
|
| Gastrointestinal Tract | 6 | 2020 | 215 | 0.600 |
Why?
|
| Family Characteristics | 2 | 2018 | 78 | 0.600 |
Why?
|
| Stomach Diseases | 1 | 2018 | 57 | 0.580 |
Why?
|
| Eating | 7 | 2019 | 368 | 0.580 |
Why?
|
| Meals | 1 | 2018 | 57 | 0.580 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 16 | 0.570 |
Why?
|
| Body Mass Index | 5 | 2010 | 1562 | 0.570 |
Why?
|
| Energy Intake | 11 | 2018 | 493 | 0.570 |
Why?
|
| Malaria | 4 | 2021 | 86 | 0.570 |
Why?
|
| Iron, Dietary | 2 | 2015 | 16 | 0.560 |
Why?
|
| Ethiopia | 8 | 2025 | 21 | 0.550 |
Why?
|
| Proteobacteria | 1 | 2016 | 19 | 0.540 |
Why?
|
| Bacteria | 6 | 2020 | 483 | 0.530 |
Why?
|
| Breast Feeding | 6 | 2022 | 220 | 0.530 |
Why?
|
| Schools | 1 | 2018 | 220 | 0.520 |
Why?
|
| Betaine | 1 | 2016 | 22 | 0.520 |
Why?
|
| Methylamines | 1 | 2016 | 19 | 0.520 |
Why?
|
| International Cooperation | 1 | 2017 | 157 | 0.520 |
Why?
|
| Jejunal Diseases | 1 | 2016 | 15 | 0.510 |
Why?
|
| Animals | 29 | 2025 | 34046 | 0.510 |
Why?
|
| Serum | 1 | 2016 | 45 | 0.510 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 1585 | 0.510 |
Why?
|
| Duodenitis | 1 | 2016 | 14 | 0.510 |
Why?
|
| Global Health | 3 | 2017 | 561 | 0.510 |
Why?
|
| Programming, Linear | 2 | 2015 | 4 | 0.500 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 81 | 0.490 |
Why?
|
| Deficiency Diseases | 2 | 2018 | 11 | 0.490 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 141 | 0.490 |
Why?
|
| Infant, Newborn | 17 | 2023 | 8199 | 0.490 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 206 | 0.480 |
Why?
|
| Anemia | 2 | 2019 | 339 | 0.480 |
Why?
|
| Endotoxins | 1 | 2015 | 48 | 0.480 |
Why?
|
| Research | 1 | 2017 | 263 | 0.480 |
Why?
|
| Anti-HIV Agents | 4 | 2014 | 316 | 0.470 |
Why?
|
| Nutritional Requirements | 5 | 2017 | 181 | 0.470 |
Why?
|
| Parity | 1 | 2015 | 78 | 0.470 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 241 | 0.460 |
Why?
|
| Fatty Acids | 1 | 2017 | 347 | 0.460 |
Why?
|
| Fetal Development | 1 | 2016 | 132 | 0.450 |
Why?
|
| Environmental Illness | 1 | 2014 | 2 | 0.450 |
Why?
|
| Arachis | 7 | 2020 | 73 | 0.450 |
Why?
|
| Protein Deficiency | 2 | 2013 | 20 | 0.440 |
Why?
|
| Edema | 4 | 2009 | 137 | 0.440 |
Why?
|
| Gastrointestinal Agents | 2 | 2014 | 60 | 0.440 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 430 | 0.440 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 239 | 0.440 |
Why?
|
| Antibodies | 1 | 2015 | 374 | 0.440 |
Why?
|
| Risk Factors | 16 | 2021 | 10281 | 0.430 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2022 | 236 | 0.420 |
Why?
|
| Body Composition | 2 | 2020 | 522 | 0.420 |
Why?
|
| Inflammation | 3 | 2021 | 1431 | 0.410 |
Why?
|
| Edible Grain | 3 | 2023 | 45 | 0.410 |
Why?
|
| Biomarkers | 10 | 2024 | 3069 | 0.410 |
Why?
|
| Energy Metabolism | 4 | 2020 | 767 | 0.400 |
Why?
|
| Gastroenteritis | 1 | 2015 | 349 | 0.400 |
Why?
|
| Chromatography, Liquid | 4 | 2017 | 196 | 0.400 |
Why?
|
| Acute-Phase Reaction | 3 | 2013 | 12 | 0.400 |
Why?
|
| Immunity | 1 | 2013 | 193 | 0.390 |
Why?
|
| Child Welfare | 2 | 2009 | 64 | 0.390 |
Why?
|
| Urea | 3 | 2002 | 226 | 0.380 |
Why?
|
| Seeds | 4 | 2017 | 42 | 0.380 |
Why?
|
| Rural Health | 7 | 2017 | 50 | 0.360 |
Why?
|
| Diarrhea, Infantile | 1 | 2011 | 36 | 0.360 |
Why?
|
| Kenya | 5 | 2020 | 52 | 0.350 |
Why?
|
| Community Health Centers | 2 | 2009 | 39 | 0.350 |
Why?
|
| Linear Models | 4 | 2015 | 681 | 0.350 |
Why?
|
| Precision Medicine | 1 | 2013 | 319 | 0.340 |
Why?
|
| India | 3 | 2021 | 214 | 0.340 |
Why?
|
| Homeostasis | 5 | 2015 | 700 | 0.340 |
Why?
|
| Pregnancy | 9 | 2024 | 7174 | 0.340 |
Why?
|
| Ghana | 3 | 2020 | 17 | 0.330 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 5163 | 0.330 |
Why?
|
| Whey Proteins | 3 | 2016 | 6 | 0.330 |
Why?
|
| Milk, Human | 2 | 2015 | 300 | 0.330 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 635 | 0.320 |
Why?
|
| Nutrition Disorders | 2 | 2002 | 32 | 0.320 |
Why?
|
| Rifamycins | 1 | 2009 | 21 | 0.320 |
Why?
|
| Fever | 2 | 2011 | 298 | 0.320 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 3435 | 0.310 |
Why?
|
| Oxidation-Reduction | 5 | 2017 | 440 | 0.310 |
Why?
|
| Sprue, Tropical | 2 | 2019 | 3 | 0.310 |
Why?
|
| Adult | 19 | 2024 | 29562 | 0.310 |
Why?
|
| Lipids | 5 | 2024 | 518 | 0.310 |
Why?
|
| Dietary Fiber | 3 | 2018 | 74 | 0.300 |
Why?
|
| Muramidase | 2 | 2019 | 94 | 0.300 |
Why?
|
| Hygiene | 2 | 2019 | 26 | 0.300 |
Why?
|
| Metagenome | 3 | 2015 | 149 | 0.300 |
Why?
|
| Nigeria | 4 | 2013 | 79 | 0.300 |
Why?
|
| Lactoferrin | 2 | 2019 | 78 | 0.290 |
Why?
|
| Dysbiosis | 2 | 2021 | 122 | 0.290 |
Why?
|
| Cluster Analysis | 4 | 2021 | 398 | 0.290 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2009 | 267 | 0.280 |
Why?
|
| Arm | 3 | 2020 | 81 | 0.280 |
Why?
|
| Dairy Products | 2 | 2019 | 45 | 0.280 |
Why?
|
| Body Weight | 7 | 2016 | 991 | 0.270 |
Why?
|
| Sepsis | 3 | 2008 | 478 | 0.270 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 2902 | 0.270 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2014 | 231 | 0.270 |
Why?
|
| Single-Blind Method | 6 | 2018 | 237 | 0.270 |
Why?
|
| Food Contamination | 1 | 2006 | 23 | 0.270 |
Why?
|
| Research Design | 3 | 2021 | 693 | 0.260 |
Why?
|
| Urine | 2 | 2018 | 90 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 1268 | 0.260 |
Why?
|
| Recurrence | 6 | 2020 | 1420 | 0.250 |
Why?
|
| Pneumonia | 3 | 2006 | 323 | 0.250 |
Why?
|
| Africa South of the Sahara | 5 | 2014 | 115 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2023 | 1116 | 0.250 |
Why?
|
| Carbon Dioxide | 2 | 2004 | 277 | 0.250 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2006 | 121 | 0.250 |
Why?
|
| Hydrocortisone | 1 | 2006 | 217 | 0.240 |
Why?
|
| Cattle | 4 | 2021 | 565 | 0.240 |
Why?
|
| Food Handling | 3 | 2019 | 18 | 0.240 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 1240 | 0.240 |
Why?
|
| Iron | 2 | 2011 | 266 | 0.240 |
Why?
|
| Environmental Exposure | 2 | 2017 | 220 | 0.240 |
Why?
|
| Adolescent | 13 | 2022 | 19336 | 0.230 |
Why?
|
| Africa | 4 | 2018 | 133 | 0.230 |
Why?
|
| Respiratory Tract Infections | 3 | 1999 | 270 | 0.230 |
Why?
|
| Hospitalization | 4 | 2021 | 1780 | 0.230 |
Why?
|
| Fish Oils | 2 | 2015 | 83 | 0.230 |
Why?
|
| Docosahexaenoic Acids | 2 | 2015 | 66 | 0.230 |
Why?
|
| Linoleic Acid | 2 | 2022 | 15 | 0.230 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2881 | 0.220 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 607 | 0.220 |
Why?
|
| World Health Organization | 5 | 2015 | 101 | 0.220 |
Why?
|
| Feasibility Studies | 3 | 2016 | 759 | 0.210 |
Why?
|
| Cysteine | 1 | 2024 | 136 | 0.210 |
Why?
|
| Birth Weight | 2 | 2022 | 345 | 0.210 |
Why?
|
| Child Health Services | 2 | 2018 | 86 | 0.210 |
Why?
|
| Health Status | 3 | 2016 | 376 | 0.200 |
Why?
|
| Polyomavirus | 2 | 2012 | 32 | 0.200 |
Why?
|
| Metadata | 1 | 2022 | 5 | 0.200 |
Why?
|
| Young Adult | 9 | 2021 | 9047 | 0.200 |
Why?
|
| Biological Availability | 5 | 2015 | 136 | 0.200 |
Why?
|
| Cachexia | 2 | 2023 | 47 | 0.200 |
Why?
|
| Bangladesh | 1 | 2022 | 22 | 0.200 |
Why?
|
| Religious Missions | 1 | 2002 | 2 | 0.200 |
Why?
|
| Intention to Treat Analysis | 2 | 2019 | 66 | 0.200 |
Why?
|
| Maternal Age | 1 | 2022 | 134 | 0.200 |
Why?
|
| Time Factors | 8 | 2018 | 6319 | 0.190 |
Why?
|
| Starvation | 1 | 2002 | 15 | 0.190 |
Why?
|
| Proteins | 2 | 1998 | 1036 | 0.190 |
Why?
|
| Vitamin A Deficiency | 2 | 2013 | 13 | 0.190 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 164 | 0.190 |
Why?
|
| Plants, Genetically Modified | 2 | 2012 | 42 | 0.190 |
Why?
|
| Vaginal Diseases | 1 | 2021 | 17 | 0.190 |
Why?
|
| Antiprotozoal Agents | 1 | 2021 | 37 | 0.190 |
Why?
|
| Azithromycin | 1 | 2021 | 44 | 0.180 |
Why?
|
| Recommended Dietary Allowances | 3 | 2018 | 23 | 0.180 |
Why?
|
| Cohort Studies | 6 | 2023 | 4805 | 0.180 |
Why?
|
| Cause of Death | 2 | 2001 | 474 | 0.180 |
Why?
|
| Fluid Therapy | 2 | 2014 | 128 | 0.180 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 256 | 0.180 |
Why?
|
| Nutritional Sciences | 1 | 2021 | 76 | 0.180 |
Why?
|
| Regression Analysis | 5 | 2015 | 779 | 0.180 |
Why?
|
| Genome, Viral | 3 | 2017 | 168 | 0.180 |
Why?
|
| Age Factors | 6 | 2018 | 2822 | 0.170 |
Why?
|
| Disclosure | 1 | 2021 | 151 | 0.170 |
Why?
|
| Longitudinal Studies | 6 | 2025 | 1327 | 0.170 |
Why?
|
| Tyrosine | 1 | 2000 | 150 | 0.170 |
Why?
|
| Publishing | 1 | 2021 | 110 | 0.170 |
Why?
|
| Egg White | 1 | 2000 | 10 | 0.170 |
Why?
|
| Sugars | 1 | 2020 | 15 | 0.170 |
Why?
|
| Powders | 2 | 2018 | 24 | 0.170 |
Why?
|
| Income | 1 | 2020 | 133 | 0.170 |
Why?
|
| Tryptophan | 1 | 2000 | 90 | 0.160 |
Why?
|
| Zimbabwe | 1 | 2019 | 10 | 0.160 |
Why?
|
| Bacteriophages | 1 | 2020 | 87 | 0.160 |
Why?
|
| Hypophosphatemia | 1 | 1998 | 10 | 0.160 |
Why?
|
| Meat | 1 | 2019 | 48 | 0.160 |
Why?
|
| Child Mortality | 2 | 2009 | 23 | 0.150 |
Why?
|
| Drinking Water | 2 | 2022 | 14 | 0.150 |
Why?
|
| Food Ingredients | 1 | 2018 | 1 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 198 | 0.150 |
Why?
|
| Standard of Care | 1 | 2019 | 130 | 0.150 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 589 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 341 | 0.150 |
Why?
|
| Urban Health Services | 1 | 2018 | 22 | 0.150 |
Why?
|
| Rural Health Services | 1 | 2018 | 26 | 0.150 |
Why?
|
| Lipid Metabolism | 2 | 2018 | 356 | 0.150 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2018 | 48 | 0.150 |
Why?
|
| Viral Load | 2 | 2010 | 383 | 0.140 |
Why?
|
| Water | 1 | 2019 | 186 | 0.140 |
Why?
|
| Patient Discharge | 2 | 2020 | 490 | 0.140 |
Why?
|
| Prevalence | 6 | 2025 | 2448 | 0.140 |
Why?
|
| Retrospective Studies | 9 | 2023 | 16336 | 0.140 |
Why?
|
| Egg Proteins | 1 | 1997 | 55 | 0.140 |
Why?
|
| Pediatrics | 2 | 2009 | 1165 | 0.140 |
Why?
|
| Logistic Models | 3 | 2012 | 1811 | 0.140 |
Why?
|
| Diet Records | 3 | 2019 | 74 | 0.140 |
Why?
|
| United Nations | 1 | 2017 | 12 | 0.140 |
Why?
|
| RNA Virus Infections | 1 | 2017 | 7 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2015 | 79 | 0.140 |
Why?
|
| RNA Viruses | 1 | 2017 | 36 | 0.140 |
Why?
|
| Polyphenols | 1 | 2017 | 19 | 0.140 |
Why?
|
| Carbon Isotopes | 3 | 2004 | 277 | 0.140 |
Why?
|
| Health Services | 1 | 2017 | 71 | 0.140 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 147 | 0.140 |
Why?
|
| Social Class | 1 | 2018 | 190 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2017 | 76 | 0.130 |
Why?
|
| Cooking | 2 | 2018 | 38 | 0.130 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 870 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 187 | 0.130 |
Why?
|
| Swine | 1 | 2020 | 1192 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2018 | 185 | 0.130 |
Why?
|
| Incidence | 4 | 2015 | 3138 | 0.130 |
Why?
|
| Glycerophospholipids | 1 | 2016 | 7 | 0.130 |
Why?
|
| Home Nursing | 3 | 2004 | 16 | 0.130 |
Why?
|
| Case-Control Studies | 5 | 2019 | 3287 | 0.130 |
Why?
|
| Failure to Thrive | 1 | 2016 | 90 | 0.130 |
Why?
|
| Glutathione | 1 | 2017 | 193 | 0.130 |
Why?
|
| Soybean Proteins | 1 | 2016 | 17 | 0.130 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2015 | 24 | 0.130 |
Why?
|
| Tuberculosis | 2 | 2008 | 519 | 0.130 |
Why?
|
| Sphingolipids | 1 | 2016 | 28 | 0.130 |
Why?
|
| Digestion | 1 | 2016 | 41 | 0.130 |
Why?
|
| Potassium | 1 | 1997 | 280 | 0.130 |
Why?
|
| Pakistan | 1 | 2016 | 75 | 0.130 |
Why?
|
| Emulsifying Agents | 1 | 2015 | 2 | 0.130 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 165 | 0.120 |
Why?
|
| Quality of Life | 3 | 2010 | 1943 | 0.120 |
Why?
|
| Disease Progression | 2 | 2014 | 2058 | 0.120 |
Why?
|
| Viscosity | 1 | 2015 | 36 | 0.120 |
Why?
|
| Oleic Acid | 1 | 2015 | 15 | 0.120 |
Why?
|
| DNA Viruses | 1 | 2015 | 33 | 0.120 |
Why?
|
| Cervical Vertebrae | 1 | 1996 | 114 | 0.120 |
Why?
|
| Twins | 1 | 2015 | 69 | 0.120 |
Why?
|
| Twin Studies as Topic | 1 | 2015 | 15 | 0.120 |
Why?
|
| Hypoxia | 2 | 1995 | 246 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2000 | 805 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 1692 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1053 | 0.120 |
Why?
|
| DNA Methylation | 2 | 2019 | 1008 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1705 | 0.120 |
Why?
|
| Oils | 1 | 2014 | 6 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 330 | 0.120 |
Why?
|
| Germ-Free Life | 4 | 2016 | 60 | 0.120 |
Why?
|
| Infant Formula | 1 | 2015 | 97 | 0.120 |
Why?
|
| Bile Acids and Salts | 1 | 2017 | 242 | 0.120 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 315 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 348 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2013 | 663 | 0.110 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 65 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2017 | 538 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2015 | 1397 | 0.110 |
Why?
|
| Critical Care | 1 | 2000 | 656 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2016 | 241 | 0.110 |
Why?
|
| Immunoglobulin A | 1 | 2015 | 208 | 0.110 |
Why?
|
| Metabolome | 1 | 2016 | 293 | 0.110 |
Why?
|
| Nutritional Support | 1 | 2014 | 54 | 0.110 |
Why?
|
| Caregivers | 3 | 2018 | 575 | 0.110 |
Why?
|
| Dysentery, Bacillary | 1 | 2013 | 10 | 0.110 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 83 | 0.110 |
Why?
|
| Prognosis | 3 | 2014 | 4631 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 1092 | 0.110 |
Why?
|
| C-Reactive Protein | 3 | 2004 | 428 | 0.110 |
Why?
|
| Placebos | 1 | 2014 | 241 | 0.110 |
Why?
|
| Recreation | 1 | 1993 | 19 | 0.110 |
Why?
|
| Lung Diseases | 1 | 1997 | 380 | 0.110 |
Why?
|
| Measles | 1 | 2013 | 40 | 0.100 |
Why?
|
| Morbidity | 2 | 2014 | 248 | 0.100 |
Why?
|
| Reference Values | 2 | 2015 | 710 | 0.100 |
Why?
|
| Breath Tests | 2 | 2004 | 178 | 0.100 |
Why?
|
| Respiration | 1 | 1993 | 119 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 71 | 0.100 |
Why?
|
| Dietary Sucrose | 1 | 2012 | 41 | 0.100 |
Why?
|
| Carrier State | 1 | 1993 | 76 | 0.100 |
Why?
|
| Haemophilus influenzae | 1 | 1993 | 130 | 0.100 |
Why?
|
| Diseases in Twins | 1 | 2013 | 94 | 0.100 |
Why?
|
| Gastritis | 1 | 2015 | 371 | 0.100 |
Why?
|
| Colon | 1 | 2015 | 349 | 0.100 |
Why?
|
| Plant Roots | 1 | 2012 | 22 | 0.100 |
Why?
|
| Nose | 1 | 1993 | 93 | 0.100 |
Why?
|
| Atrophy | 1 | 2012 | 230 | 0.100 |
Why?
|
| Polyomavirus Infections | 1 | 2012 | 88 | 0.100 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2014 | 242 | 0.100 |
Why?
|
| Transcriptome | 1 | 2018 | 953 | 0.100 |
Why?
|
| Sucrose | 2 | 2009 | 39 | 0.100 |
Why?
|
| Biodiversity | 1 | 2012 | 64 | 0.100 |
Why?
|
| beta Carotene | 1 | 2012 | 41 | 0.100 |
Why?
|
| Soybean Oil | 1 | 2011 | 70 | 0.090 |
Why?
|
| Phylogeny | 4 | 2017 | 696 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2519 | 0.090 |
Why?
|
| Foods, Specialized | 1 | 2011 | 2 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2012 | 217 | 0.090 |
Why?
|
| Thinness | 2 | 2008 | 69 | 0.090 |
Why?
|
| Urinalysis | 2 | 2002 | 61 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 473 | 0.090 |
Why?
|
| Kinetics | 1 | 2013 | 1323 | 0.090 |
Why?
|
| Liver | 1 | 2018 | 1737 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4351 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2051 | 0.090 |
Why?
|
| Disease Management | 1 | 2014 | 525 | 0.090 |
Why?
|
| Risk | 1 | 2013 | 754 | 0.090 |
Why?
|
| Antigens, Bacterial | 1 | 1993 | 314 | 0.090 |
Why?
|
| Overweight | 1 | 2013 | 364 | 0.090 |
Why?
|
| Stavudine | 1 | 2010 | 1 | 0.090 |
Why?
|
| Nevirapine | 1 | 2010 | 15 | 0.090 |
Why?
|
| Lamivudine | 1 | 2010 | 25 | 0.090 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2010 | 42 | 0.080 |
Why?
|
| Case Management | 2 | 2008 | 20 | 0.080 |
Why?
|
| Mice | 6 | 2018 | 17573 | 0.080 |
Why?
|
| Regional Health Planning | 1 | 2009 | 6 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2010 | 118 | 0.080 |
Why?
|
| Glycosaminoglycans | 1 | 2009 | 33 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 1993 | 370 | 0.080 |
Why?
|
| Sleep | 1 | 2012 | 344 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 110 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2004 | 419 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2010 | 339 | 0.080 |
Why?
|
| Convalescence | 1 | 2008 | 4 | 0.080 |
Why?
|
| Tropical Climate | 1 | 2009 | 49 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2000 | 79 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2011 | 3728 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2009 | 173 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 1757 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2009 | 267 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 383 | 0.070 |
Why?
|
| Physician's Role | 1 | 2009 | 166 | 0.070 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2010 | 136 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 264 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2008 | 146 | 0.070 |
Why?
|
| Food Technology | 1 | 2006 | 2 | 0.070 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2006 | 2 | 0.070 |
Why?
|
| Consumer Product Safety | 1 | 2006 | 30 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 1165 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2008 | 310 | 0.070 |
Why?
|
| Diet Surveys | 1 | 2006 | 98 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 678 | 0.060 |
Why?
|
| Minerals | 2 | 2016 | 57 | 0.060 |
Why?
|
| Lactobacillus | 1 | 2005 | 42 | 0.060 |
Why?
|
| Middle Aged | 5 | 2015 | 26867 | 0.060 |
Why?
|
| Vitamins | 2 | 2016 | 108 | 0.060 |
Why?
|
| Nutrition Policy | 2 | 2017 | 102 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2020 | 1190 | 0.060 |
Why?
|
| Mothers | 2 | 2022 | 354 | 0.060 |
Why?
|
| Gambia | 3 | 2012 | 28 | 0.060 |
Why?
|
| Leukocytes | 1 | 2006 | 205 | 0.060 |
Why?
|
| United States | 5 | 2021 | 10906 | 0.060 |
Why?
|
| Geography | 2 | 2017 | 113 | 0.060 |
Why?
|
| Phytochemicals | 1 | 2024 | 8 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1884 | 0.050 |
Why?
|
| Aged | 3 | 2012 | 19825 | 0.050 |
Why?
|
| Livestock | 1 | 2023 | 12 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2023 | 30 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2006 | 678 | 0.050 |
Why?
|
| Environmental Microbiology | 1 | 2023 | 16 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2024 | 141 | 0.050 |
Why?
|
| Probiotics | 1 | 2005 | 213 | 0.050 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2012 | 47 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 335 | 0.050 |
Why?
|
| Zinc Isotopes | 1 | 2002 | 2 | 0.050 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2002 | 6 | 0.050 |
Why?
|
| Soil | 1 | 2022 | 57 | 0.050 |
Why?
|
| Hunger | 1 | 2002 | 46 | 0.050 |
Why?
|
| Vegetables | 1 | 2024 | 262 | 0.050 |
Why?
|
| Base Sequence | 2 | 2017 | 3090 | 0.050 |
Why?
|
| Growth and Development | 1 | 2021 | 22 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2008 | 1507 | 0.050 |
Why?
|
| Carbon | 1 | 2022 | 92 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4375 | 0.050 |
Why?
|
| Editorial Policies | 1 | 2021 | 53 | 0.050 |
Why?
|
| Radioactive Tracers | 1 | 2000 | 21 | 0.040 |
Why?
|
| Twins, Monozygotic | 2 | 2012 | 117 | 0.040 |
Why?
|
| Seasons | 3 | 2010 | 310 | 0.040 |
Why?
|
| Isomerism | 1 | 2000 | 31 | 0.040 |
Why?
|
| South Sudan | 1 | 2020 | 2 | 0.040 |
Why?
|
| Rhamnose | 2 | 1997 | 6 | 0.040 |
Why?
|
| Sheep | 1 | 2021 | 219 | 0.040 |
Why?
|
| Health Promotion | 1 | 2024 | 389 | 0.040 |
Why?
|
| Chickens | 1 | 2021 | 636 | 0.040 |
Why?
|
| Dried Blood Spot Testing | 1 | 2020 | 21 | 0.040 |
Why?
|
| Mammals | 1 | 2021 | 253 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2020 | 42 | 0.040 |
Why?
|
| Nursing Care | 1 | 2000 | 7 | 0.040 |
Why?
|
| Jamaica | 1 | 2019 | 25 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 351 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 52 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 33 | 0.040 |
Why?
|
| Fermentation | 1 | 2019 | 66 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2000 | 285 | 0.040 |
Why?
|
| Fagaceae | 1 | 2019 | 1 | 0.040 |
Why?
|
| Poultry | 1 | 2019 | 6 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 165 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6583 | 0.040 |
Why?
|
| Fishes | 1 | 2019 | 38 | 0.040 |
Why?
|
| West Indies | 1 | 2018 | 7 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 163 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2015 | 475 | 0.040 |
Why?
|
| Taste Perception | 1 | 2018 | 5 | 0.040 |
Why?
|
| Meningitis, Bacterial | 1 | 1999 | 93 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 324 | 0.040 |
Why?
|
| Sudan | 1 | 2018 | 4 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 107 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2018 | 12 | 0.040 |
Why?
|
| Cytokines | 1 | 2004 | 1289 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2018 | 63 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 2154 | 0.040 |
Why?
|
| Animal Feed | 1 | 2018 | 79 | 0.040 |
Why?
|
| Malaria, Falciparum | 1 | 1998 | 46 | 0.040 |
Why?
|
| Flavonoids | 1 | 2018 | 78 | 0.040 |
Why?
|
| Survivors | 1 | 2019 | 334 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 276 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3877 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1997 | 83 | 0.030 |
Why?
|
| Food-Drug Interactions | 1 | 2017 | 10 | 0.030 |
Why?
|
| Nitrogen Isotopes | 1 | 1997 | 63 | 0.030 |
Why?
|
| Macaca nemestrina | 1 | 2017 | 17 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 1999 | 160 | 0.030 |
Why?
|
| Albumins | 1 | 1997 | 92 | 0.030 |
Why?
|
| Virus Diseases | 1 | 1999 | 280 | 0.030 |
Why?
|
| Immobilization | 1 | 1996 | 24 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1999 | 309 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2000 | 1257 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2016 | 55 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2017 | 241 | 0.030 |
Why?
|
| Joint Dislocations | 1 | 1996 | 23 | 0.030 |
Why?
|
| Parasitic Diseases | 1 | 2017 | 61 | 0.030 |
Why?
|
| Spinal Injuries | 1 | 1996 | 29 | 0.030 |
Why?
|
| Whey | 1 | 2016 | 1 | 0.030 |
Why?
|
| Clostridiales | 1 | 2016 | 9 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 190 | 0.030 |
Why?
|
| Mozambique | 1 | 2016 | 20 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2017 | 253 | 0.030 |
Why?
|
| Spinal Fractures | 1 | 1996 | 39 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 1996 | 58 | 0.030 |
Why?
|
| Child Health | 1 | 2016 | 53 | 0.030 |
Why?
|
| Femur | 1 | 2016 | 67 | 0.030 |
Why?
|
| Bone Development | 1 | 2016 | 57 | 0.030 |
Why?
|
| Contig Mapping | 1 | 2015 | 55 | 0.030 |
Why?
|
| alpha-Linolenic Acid | 1 | 2015 | 14 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 556 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2015 | 87 | 0.030 |
Why?
|
| Bifidobacterium | 1 | 2016 | 62 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2017 | 491 | 0.030 |
Why?
|
| Taste | 1 | 2015 | 31 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 621 | 0.030 |
Why?
|
| Flatulence | 1 | 2015 | 4 | 0.030 |
Why?
|
| Microbial Consortia | 1 | 2015 | 6 | 0.030 |
Why?
|
| 6-Phytase | 1 | 2015 | 3 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 90 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2015 | 81 | 0.030 |
Why?
|
| Body Size | 1 | 2015 | 55 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1108 | 0.030 |
Why?
|
| Phospholipids | 1 | 2015 | 105 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 1997 | 256 | 0.030 |
Why?
|
| Administration, Oral | 1 | 1997 | 682 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 161 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 256 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1997 | 681 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 370 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 89 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 75 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 820 | 0.030 |
Why?
|
| Survival Rate | 1 | 1998 | 2060 | 0.030 |
Why?
|
| Missouri | 1 | 1993 | 36 | 0.030 |
Why?
|
| Motor Skills | 1 | 2013 | 83 | 0.030 |
Why?
|
| Papua New Guinea | 1 | 1993 | 5 | 0.030 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 10 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 227 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2015 | 375 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 1502 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2013 | 56 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 465 | 0.030 |
Why?
|
| Extremities | 1 | 1993 | 83 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1993 | 68 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1697 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2012 | 286 | 0.030 |
Why?
|
| Venezuela | 1 | 2012 | 16 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2012 | 42 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 131 | 0.020 |
Why?
|
| Family | 1 | 2015 | 566 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2012 | 94 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2015 | 543 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 899 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 810 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 1993 | 135 | 0.020 |
Why?
|
| Oxygen | 1 | 1995 | 553 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 882 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2012 | 480 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 448 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2011 | 45 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 824 | 0.020 |
Why?
|
| Fertilization | 1 | 2010 | 43 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2012 | 348 | 0.020 |
Why?
|
| Health Personnel | 1 | 2015 | 504 | 0.020 |
Why?
|
| Focus Groups | 1 | 2011 | 199 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 146 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 276 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 375 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 444 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 450 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 668 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 388 | 0.020 |
Why?
|
| Fish Products | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cough | 1 | 2008 | 88 | 0.020 |
Why?
|
| South Africa | 1 | 2008 | 99 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 3448 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 1179 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2005 | 33 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2012 | 1497 | 0.020 |
Why?
|
| Selenium | 1 | 2005 | 22 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4254 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2006 | 309 | 0.010 |
Why?
|
| Vitamin E | 1 | 2005 | 67 | 0.010 |
Why?
|
| Riboflavin | 1 | 2005 | 38 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2005 | 72 | 0.010 |
Why?
|
| Tropical Medicine | 1 | 2005 | 104 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 2004 | 121 | 0.010 |
Why?
|
| Mental Recall | 1 | 2004 | 143 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1999 | 94 | 0.010 |
Why?
|
| Blood | 1 | 1999 | 104 | 0.010 |
Why?
|
| Health Facilities | 1 | 1999 | 60 | 0.010 |
Why?
|
| Culture Media | 1 | 1999 | 182 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1997 | 41 | 0.010 |
Why?
|
| Rehabilitation Centers | 1 | 1997 | 36 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1707 | 0.010 |
Why?
|
| Milk Hypersensitivity | 1 | 1997 | 14 | 0.010 |
Why?
|
| New Guinea | 1 | 1995 | 3 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 1995 | 90 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 1999 | 770 | 0.010 |
Why?
|
| Oximetry | 1 | 1995 | 168 | 0.010 |
Why?
|